Subclinical States of Glucose Intolerance and Risk of Death in the U.S.
Open Access
- 1 March 2001
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 24 (3) , 447-453
- https://doi.org/10.2337/diacare.24.3.447
Abstract
OBJECTIVE—Although clinically evident type 2 diabetes is a well-established cause of mortality, less is known about subclinical states of glucose intolerance.Keywords
This publication has 27 references indexed in Scilit:
- The Cost-effectiveness of Screening for Type 2 DiabetesJAMA, 1998
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39BMJ, 1998
- Glucose tolerance and mortality, including a substudy of tolbutamide treatmentDiabetologia, 1997
- Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesDiabetes, 1997
- Diabetes, Asymptomatic Hyperglycemia, and 22-Year Mortality in Black and White Men: The Chicago Heart Association Detection Project in Industry StudyDiabetes Care, 1997
- Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart ProgramDiabetes Care, 1996
- Screening for NIDDM in Nonpregnant Adults: A review of principles, screening tests, and recommendationsDiabetes Care, 1995
- The Effect of Diabetes and Impaired Glucose Tolerance on Mortality in MaltaDiabetic Medicine, 1994
- Ten-year Follow-up of Subjects with Impaired Glucose Tolerance: Prevention of Diabetes by Tolbutamide and Diet RegulationDiabetes, 1980
- Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulationDiabetes, 1980